Fortis’s Agilus challenge deepens

Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.

9 October, 202410 min
0
Fortis’s Agilus challenge deepens

You may also like

Business
Story image

Ten business developments for 2026

Who’s going to lead the IPO party, what’s going to drive the market, where are some of the leading businesses headed, and more.

Business
Story image

Devi Shetty’s contrarian bet in expanding to the United Kingdom

On the surface, Narayana Health’s latest acquisition holds promise. But a closer look suggests that the UK’s Practice Plus Group will need a bit of a turnaround before it can start yielding results.

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.